In 2023, Germany led the European production of chemical and pharmaceutical products with a value of 201.35 billion euros, reflecting a modest increase of 0.22% from the previous year. Italy followed with 81.41 billion euros, growing by 0.2%. The Netherlands and Belgium reported more significant increases of 1.35% and 2.46% respectively, with values at 62.79 and 59.94 billion euros. Spain saw a growth of 1.03%, while Austria and Finland reported higher growth rates of 2.16% and 2.22%. Greece showed substantial growth at 2.89%, Slovenia at 1.98%, and Lithuania at 1.65%, with smaller economies like Slovakia contracting at -0.38%. Luxembourg and Estonia maintained modest growth rates at 1.99% and 0.93%. Over the last five years, these countries exhibited varied compound annual growth rates, indicating diverse industry dynamics.
Future trends to watch include the increasing investment in green technologies and sustainable chemical production. There is a significant emphasis on innovation driven by digitalization and automation, contributing to the sector’s growth and transformation. Geopolitical developments and regulatory changes will also play crucial roles in shaping the industry landscape in Europe.
Top countries in Production of Chemical and Pharmaceutical Products by Country
| # | 10 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 201,350 | 2023 | +1.13% | +0.22% | View data |
| 2 | 2 Italy | 81,410 | 2023 | +0.77% | +0.2% | View data |
| 3 | 3 Netherlands | 62,790 | 2023 | +1.81% | +1.35% | View data |
| 4 | 4 Belgium | 59,940 | 2023 | +2.02% | +2.46% | View data |
| 5 | 5 Spain | 58,310 | 2023 | +1.14% | +1.03% | View data |
| 6 | 6 Austria | 20,940 | 2023 | +2.14% | +2.16% | View data |
| 7 | 7 Finland | 12,100 | 2023 | +2.18% | +2.22% | View data |
| 8 | 8 Greece | 5,010 | 2023 | +1.44% | +2.89% | View data |
| 9 | 9 Slovenia | 4,060 | 2023 | +2.06% | +1.98% | View data |
| 10 | 10 Lithuania | 2,650 | 2023 | +2.29% | +1.65% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...